Website profile

@Oncodaily

OncoDaily is a specialized oncology news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments in the f

  • 815articles · 30d
  • 4+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 11%with images · 19 videos
  • 187avg words
articles per day
Categories
  • Health & Wellness 788
  • Medical 753
  • Health 747
  • Education & Jobs 40
  • Human Interest 24
  • Science & Technology 18
  • Education 15
  • Economy, Business & Finance 6

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Oncodaily - Oncology News
oncodaily.com > career > krishna-sharma-584940

Krishna Sharma: Happy to Take on the Role of Head of Pediatrics and Adolescent Oncology - OncoDaily

7+ hour, 42+ min ago   (73+ words) Krishna Sharma: Happy to Take on the Role of Head of Pediatrics and Adolescent Oncology Oncodaily Krishna Sharma: Happy to Take on the Role of Head of Pediatrics and Adolescent Oncology Krishna Sharma, Head of Department, Pediatrics and Adolescent Oncology…...

Google News
oncodaily.com > drug > teniposide-chemotherapy-2026

Teniposide: Mechanism of Action, Dose, Administration, Clinical Uses, and Side Effects - Oncology News, Insights, Stories by OncoDaily

2+ day, 16+ hour ago   (605+ words) VIRO 2026 – Global Voices in Renal Oncology Joe Biden Raises Prostate Cancer Awareness, Urges Men to Discuss Screening With Their Doctors HHS Announces Four Key FDA Leadership Selections Across CDER, CBER, CTP and AI Eric Singhi: 10 WCLC26 Abstracts Beyond the Presidentials to…...

Oncodaily - Oncology News
oncodaily.com > voices > simmons-cancer-center-583971

Congratulations to Simmons Cancer Center Members Receiving UT Southwestern Medical Center Leaders in Clinical Excellence Awards! - OncoDaily

2+ day, 21+ hour ago   (64+ words) Congratulations to Simmons Cancer Center Members Receiving UT Southwestern Medical Center Leaders in Clinical Excellence Awards! oncodaily.com Congratulations to Simmons Cancer Center Members Receiving UT Southwestern Medical Center Leaders in Clinical Excellence Awards! UTSW Simmons Cancer Center shared on…...

Oncodaily - Oncology News
oncodaily.com > science > david-spetzler-pancreatic-cancer-583821

David Spetzler: What If We Could Know Which Pancreatic Cancer Treatment Is More Likely to Work? - OncoDaily

2+ day, 22+ hour ago   (254+ words) David Spetzler, President of Caris Life Sciences, shared on LinkedIn: “Nearly half the patients in our new pancreatic study received a different first-line treatment than the one our model identified as more likely to benefit them. The research, recently published…...

Oncodaily - Oncology News
oncodaily.com > voices > michael-oberreiter-583093

Michael Oberreiter: From Health Economics to the Economics of Health - OncoDaily

4+ day, 3+ hour ago   (295+ words) Michael Oberreiter, Head of External Affairs International at Roche, shared on LinkedIn: “Sunday afternoons are a good time to let my brain wander off. Next destination: is it time to move from health economics to the economics of health? I’ve…...

Oncodaily - Oncology News
oncodaily.com > voices > the-babak-lab-582830

Merck and Moderna Announce Positive Phase 3 Results for Intismeran Autogene Plus Pembrolizumab in High-Risk Melanoma - The Babak Lab - OncoDaily

5+ day, 26+ min ago   (88+ words) The Babak Lab shared on LinkedIn: “Merck and Moderna have announced positive top-line results from the Phase 3 INTerpath-001 trial of intismeran autogene (V940) + pembrolizumab in patients with resected high-risk melanoma. INTerpath-001 is the first positive Phase 3 trial of an individualized neoantigen…...

Oncodaily - Oncology News
oncodaily.com > voices > christopher-de-clinton-conway-582081

Christopher de Clinton Conway: US–Australia Collaboration in Biotechnology - OncoDaily

5+ day, 4+ hour ago   (123+ words) “The Search for New Cures Is Broken An important Guest Essay from Ruxandra Teslo, in today’s The New York Times makes a compelling case: America cannot afford to lose its edge in biotechnology. Dr. Teslo highlights how Australia has become…...

Oncodaily - Oncology News
oncodaily.com > voices > jean-kaseya-healthcare-582245

Jean Kaseya: Three Zeros, One Deadline - A Roadmap for Healthier Futures by 2030 - OncoDaily

5+ day, 21+ hour ago   (136+ words) Jean Kaseya, Director General at Africa CDC, shared on X: “The AU Champion’s Roadmap on Reproductive, Maternal, Newborn, Child and Adolescent Health 2026–2030 is an important opportunity to turn our commitments into action and ensure that every mother, newborn, child and adolescent…...

Google News
oncodaily.com > career > andrew-joyce-581990

Andrew Joyce: Excited to Join Roche as Head of Corporate Strategy and Sustainability Communications

6+ day, 2+ hour ago   (88+ words) Andrew Joyce, Head of Corporate Strategy and Sustainability Communications at Roche, shared on LinkedIn: “I’m going to be taking on a new role as head of corporate strategy and sustainability communications at Roche. As a result, I’m looking for a…...

Oncodaily - Oncology News
oncodaily.com > voices > kathleen-schmeler-581614

Kathleen Schmeler: Privilege to Spend the Week with Zambian Ministry of Health and CDH - OncoDaily

1+ week, 2+ hour ago   (160+ words) Kathleen Schmeler, Associate Vice President of Global Oncology, shared on LinkedIn: “It was a privilege for our team from UT MD Anderson to spend the week with our colleagues from the Zambian Ministry of Health and the Cancer Diseases Hospital…...